Key Insights

Highlights

Treatment Research

3 treatments under study, led by Cergenx Wave

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

50%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Not Yet Recruiting1
Recruiting1

Clinical Trials (2)

Showing 2 of 2 trials
NCT07857070Not Yet Recruiting

Newborn Brain Assessment - CergenX Wave

NCT05648812Phase 3Recruiting

Neonatal Brain Ultrasound With CEUS and Elastography

Showing all 2 trials

Research Network

Common Treatments

  • Cergenx Wave1
  • Brain Contrast Enhanced Ultrasound Brain Ultrasound Elastography1
  • Sulfur Hexafluoride1

Active Sponsors

  • INFANT centre, University College Cork, Republic of Ireland1
  • Varsinais-Suomen hyvinvointialue1
  • CergenX Limited1
  • Turku University Hospital1

Top Investigators

Related Conditions

  • Neonatal Hypoxic Ischemic Encephalopathy1
  • Neonatal Stroke1
  • Vastasyntyneiden Hypoksisiskeeminen Aivovaurio Vastasyntyneiden Aivohalvaus Vastasyntyneiden Keskushermostoinfektiot Entiset Keskoset Lasketussa Ajassa1
  • Neonatal Encephalopathy1
  • Neonatal Encephalopathy Neonatal Hypoxicischemic Encephalopathy1

Activity Timeline